SMARCA4 and sarcoma: Inclusion of other SWI/SNF immunomarkers, such as ARID1A, in the differential diagnostic workup of poorly differentiated sarcoma not fitting well-known subtypes, such as SMARCB1 and SMARCA4-deficient sarcomas, is recommended.